Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

An Update in Cystic Fibrosis-Related Diabetes in Children and Adolescents

Bibliographic Data

ID15715921
AuthorsDana-Teodora Anton-Păduraru (0000-0001-8657-378X, Grigore T. Popa University of Medicine and Pharmacy), Alina Murgu (Grigore T. Popa University of Medicine and Pharmacy), Alina Mariela Murgu (Department of Mother and Child Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania), Mădălina Andreea Donos (Grigore T. Popa University of Medicine and Pharmacy, corresponding author), Felicia Trofin (0000-0002-8551-3053, Grigore T. Popa University of Medicine and Pharmacy), Alice Azoicăi (Grigore T. Popa University of Medicine and Pharmacy), Alice Nicoleta Azoicai (Department of Mother and Child Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania), Paula Popovici (Grigore T. Popa University of Medicine and Pharmacy), Aurelian Bogdan Stana (Grigore T. Popa University of Medicine and Pharmacy), Ionela Gheorghiescu (Grigore T. Popa University of Medicine and Pharmacy), Laura Mihaela Trandafir (0000-0002-8326-7610, Grigore T. Popa University of Medicine and Pharmacy)
Year2023
Volume10
Issue12
Pages1879-1879
Publication date2023-11-30
Open AccessYes
TypeARTICLE
VenueChildren (JOURNAL)
Journal identifiersISSN: 2227-9067 • E-ISSN: 2227-9067
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/children10121879
PMID38136081
OpenAlexW4389179893
LanguageEN
Citations received1
References cited81

This paper delineates several aspects of cystic fibrosis-related diabetes (CFRD)-a common complication of cystic fibrosis (CF). CFRD exhibits a predilection for older individuals with CF, yet it also extends its influence on children and adolescents. Scientific insights postulate a potential link between CFRD and the aberrant mucus production within the pancreas, thereby culminating in pancreatic insufficiency. This, in turn, perturbs the synthesis of insulin, a pivotal endocrine hormone responsible for the regulation of glycemic levels. Standardized protocols advocate for the systematic screening of CFRD among all individuals with CF, commencing at the age of 10 years using the oral glucose tolerance test (OGTT). Therapeutic modalities encompass insulin therapy, dietary adjustments, and the vigilant monitoring of glycemic parameters. The overarching objective is to maintain blood glucose levels within a targeted range to mitigate the advent of diabetic complications. Untreated or sub-optimally managed CFRD can precipitate a spectrum of deleterious health ramifications, encompassing cardiovascular afflictions, neuropathy, renal dysfunction, and ocular complications

Complication · Cystic fibrosis · Cystic fibrosis-related diabetes · Diabetes mellitus · Endocrine system · Glycemic · Hormone · Impaired glucose tolerance · Insulin · Intensive care medicine · Type 2 diabetes · Congenital Ear and Nasal Anomalies · Cystic Fibrosis Research Advances · Immunodeficiency and Autoimmune Disorders · Medicine · Endocrinology · Internal Medicine · Pediatrics

  • Role of Matsuda Index in Identifying Patients at Risk for Cystic Fibrosis-Related Diabetes Development

    Open Access•S Albayrak, Elif Arık et al.•Children•2025

  • Oral Glucose Tolerance Test in Patients with Cystic Fibrosis Compared to the Overweight and Obese

    Open Access•Mirela Mogoi, Liviu Pop et al.•Children•2022

Citations per year1
Citation span2025 - 2025 (1)
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae